Nagayama Shinichi | Shin Nippon Biomedica Laboratories, Ltd.
スポンサーリンク
概要
関連著者
-
Nagata Ryoichi
Shin Nippon Biomedical Laboratories (snbl) Ltd.
-
Nagata Ryoichi
Shin Nippon Biomedical Laboratories Ltd.
-
Kito Go
新日本科学
-
Kito Go
Shin Nippon Biomedical Laboratories (snbl) Ltd
-
Nagata Ryoichi
Toxicology Division Shin Nippon Biomedical Laboratories
-
Nagayama Shinichi
Shin Nippon Biomedica Laboratories, Ltd.
-
Nagayama Shinichi
Shin Nippon Biomedical Laboratories Ltd.
-
Nagata Ryoichi
Shin Nippon Biomedical Lab. Ltd.
-
Kameyama Asako
Department Of Physiology Faculty Of Medicine Kagoshima University
-
Kameyama Masaki
Department Of Physiology Faculty Of Medicine Kagoshima University
-
Kameyama Masaki
Department Of Aeronautics And Space Engineering Tohoku University
-
Kuwano Koichi
Shin Nippon Biomedical Laboratories Ltd.
-
Pinelli Christina
Shin Nippon Biomedica Laboratories, Ltd.
-
Uchimura Nao
Shin Nippon Biomedica Laboratories, Ltd.
-
Matsuo Junko
Shin Nippon Biomedica Laboratories, Ltd.
-
Liying Hao
Department of Physiology, Faculty of Medicine, Kagoshima University
-
Liying Hao
Department Of Physiology Faculty Of Medicine Kagoshima University
-
Uchimura Nao
Shin Nippon Biomedical Laboratories Ltd.
-
Matsuo Junko
Shin Nippon Biomedical Laboratories Ltd.
-
Pinelli Christina
Shin Nippon Biomedical Laboratories Ltd.
-
Kamenosono Takeshi
Shin Nippon Biomedical Laboratories, Ltd., Drug Safety Research Laboratories
-
Kamenosono Takeshi
Shin Nippon Biomedical Laboratories Ltd. Drug Safety Research Laboratories
-
JIKUZONO Tatsuya
Shin Nippon Biomedical Laboratories (SNBL), Ltd
-
Hamada Taiji
Shin Nippon Biomedical Laboratories Ltd.
-
Hamada Taiji
Shin Nippon Biomedical Laboratories (snbl) Ltd
-
FURUKAWA Takeshi
Shin Nippon Biomedical Laboratories, Ltd.
-
Furukawa Takeshi
Shin Nippon Biomedical Laboratories Ltd.
-
Jikuzono Tatsuya
Shin Nippon Biomedical Laboratories (snbl) Ltd
著作論文
- Preclinical evaluation of the proarrhythmic risk in safety pharmacology : Effects of several drugs on HERG current and action potential of cardiac ventricular myoctytes(GENERAL SESSION BY ORAL PRESENTATION)(SAFETY PHARMACOLOGY)
- Effects of H2 blockers on HERG current and action potential of cardiac ventricular myoctytes.(GENERAL SESSION BY ORAL PRESENTATION)(SAFETY PHARMACOLOGY)
- O-39 Strategy for preclinical evaluation of the proarrhythmic risk.(Proceedings of the 27th Annual Meeting)